Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “febuxostat”

5 pharma patents match "febuxostat" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "febuxostat" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “febuxostat” · 30,257 patents in full index Clear search

  1. US 9107912

    Methods for concomitant treatment of theophylline and febuxostat

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted

  2. US 8742129

    Crystalline forms of febuxostat

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 3, 2014 · Expires May 29, 2034

    granted

  3. US 8609856

    Crystalline forms of Febuxostat

    Teva Pharmaceuticals USA, Inc. · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  4. US 8415481

    Crystalline form of febuxostat

    Teva Pharmaceuticals USA, Inc. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  5. US 8372872

    Methods for concomitant treatment of theophylline and febuxostat

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.